Interferon Beta-1B
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];
Disclaimer
WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.
Overview
Interferon Beta-1B is an immunologic adjuvant that is FDA approved for the treatment of relapsing forms of multiple sclerosis. Common adverse reactions include injection site reaction, lymphopenia, flu-like symptoms, myalgia, leukopenia, neutropenia, increased liver enzymes, headache, hypertonia, pain, rash, insomnia, abdominal pain, and asthenia.
Adult Indications and Dosage
FDA-Labeled Indications and Dosage (Adult)
There is limited information regarding Interferon Beta-1B FDA-Labeled Indications and Dosage (Adult) in the drug label.
Off-Label Use and Dosage (Adult)
Guideline-Supported Use
There is limited information regarding Off-Label Guideline-Supported Use of Interferon Beta-1B in adult patients.
Non–Guideline-Supported Use
There is limited information regarding Off-Label Non–Guideline-Supported Use of Interferon Beta-1B in adult patients.
Pediatric Indications and Dosage
FDA-Labeled Indications and Dosage (Pediatric)
There is limited information regarding Interferon Beta-1B FDA-Labeled Indications and Dosage (Pediatric) in the drug label.
Off-Label Use and Dosage (Pediatric)
Guideline-Supported Use
There is limited information regarding Off-Label Guideline-Supported Use of Interferon Beta-1B in pediatric patients.
Non–Guideline-Supported Use
There is limited information regarding Off-Label Non–Guideline-Supported Use of Interferon Beta-1B in pediatric patients.
Contraindications
There is limited information regarding Interferon Beta-1B Contraindications in the drug label.
Warnings
There is limited information regarding Interferon Beta-1B Warnings' in the drug label.
Adverse Reactions
Clinical Trials Experience
There is limited information regarding Interferon Beta-1B Clinical Trials Experience in the drug label.
Postmarketing Experience
There is limited information regarding Interferon Beta-1B Postmarketing Experience in the drug label.
Drug Interactions
There is limited information regarding Interferon Beta-1B Drug Interactions in the drug label.
Use in Specific Populations
Pregnancy
Pregnancy Category (FDA):
There is no FDA guidance on usage of Interferon Beta-1B in women who are pregnant.
Pregnancy Category (AUS):
There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Interferon Beta-1B in women who are pregnant.
Labor and Delivery
There is no FDA guidance on use of Interferon Beta-1B during labor and delivery.
Nursing Mothers
There is no FDA guidance on the use of Interferon Beta-1B in women who are nursing.
Pediatric Use
There is no FDA guidance on the use of Interferon Beta-1B in pediatric settings.
Geriatic Use
There is no FDA guidance on the use of Interferon Beta-1B in geriatric settings.
Gender
There is no FDA guidance on the use of Interferon Beta-1B with respect to specific gender populations.
Race
There is no FDA guidance on the use of Interferon Beta-1B with respect to specific racial populations.
Renal Impairment
There is no FDA guidance on the use of Interferon Beta-1B in patients with renal impairment.
Hepatic Impairment
There is no FDA guidance on the use of Interferon Beta-1B in patients with hepatic impairment.
Females of Reproductive Potential and Males
There is no FDA guidance on the use of Interferon Beta-1B in women of reproductive potentials and males.
Immunocompromised Patients
There is no FDA guidance one the use of Interferon Beta-1B in patients who are immunocompromised.
Administration and Monitoring
Administration
There is limited information regarding Interferon Beta-1B Administration in the drug label.
Monitoring
There is limited information regarding Interferon Beta-1B Monitoring in the drug label.
IV Compatibility
There is limited information regarding the compatibility of Interferon Beta-1B and IV administrations.
Overdosage
There is limited information regarding Interferon Beta-1B overdosage. If you suspect drug poisoning or overdose, please contact the National Poison Help hotline (1-800-222-1222) immediately.
Pharmacology
There is limited information regarding Interferon Beta-1B Pharmacology in the drug label.
Mechanism of Action
There is limited information regarding Interferon Beta-1B Mechanism of Action in the drug label.
Structure
There is limited information regarding Interferon Beta-1B Structure in the drug label.
Pharmacodynamics
There is limited information regarding Interferon Beta-1B Pharmacodynamics in the drug label.
Pharmacokinetics
There is limited information regarding Interferon Beta-1B Pharmacokinetics in the drug label.
Nonclinical Toxicology
There is limited information regarding Interferon Beta-1B Nonclinical Toxicology in the drug label.
Clinical Studies
There is limited information regarding Interferon Beta-1B Clinical Studies in the drug label.
How Supplied
There is limited information regarding Interferon Beta-1B How Supplied in the drug label.
Storage
There is limited information regarding Interferon Beta-1B Storage in the drug label.
Images
Drug Images
{{#ask: Page Name::Interferon Beta-1B |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}
Package and Label Display Panel
{{#ask: Label Page::Interferon Beta-1B |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}
Patient Counseling Information
There is limited information regarding Interferon Beta-1B Patient Counseling Information in the drug label.
Precautions with Alcohol
Alcohol-Interferon Beta-1B interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.
Brand Names
There is limited information regarding Interferon Beta-1B Brand Names in the drug label.
Look-Alike Drug Names
There is limited information regarding Interferon Beta-1B Look-Alike Drug Names in the drug label.
Drug Shortage Status
Price
References
The contents of this FDA label are provided by the National Library of Medicine.